Journal of Natural Products · 2007 · 50 citations · 6 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryNeuropharmacologyAromatic PlantsMedicinal PlantsNatural Product Drug DiscoveryNeurochemical PharmacologyStructure-activity Relationship AnalysisMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsMonoamine Oxidase InvolvementPharmacological ScreeningPlant-derived Natural Products
Four new prenylated xanthones, cudratricusxanthones J-M (1-4), were isolated from the CH2Cl2-soluble extract of the root bark of Cudrania tricuspidata, along with four known prenylated xanthones, isocudraxanthone K (5), cudraxanthone C (6), cudratricusxanthone A (7), and cudraxanthone L (8), and three known prenylated flavonoids, cudraflavone A (9), cudraflavanone A (10), and cudraflavone B (11). The structures of compounds 1-4 were elucidated using spectroscopic methods. Cudratricusxanthone A (7), cudraflavanone A (10), and cudraflavone B (11) showed moderate inhibitory effects on mouse brain monoamine oxidase (MAO) with IC50 values of 88.3, 89.7, and 80.0 microM, respectively.
6
Inhibition of histamine methylation by antimalarial drugs
Victor Cohn · Biochemical Pharmacology · 1965 · 61 citations
Studies on Polysaccharides from<i>Angelica acutiloba</i>
Haruki Yamada, Hiroaki Kiyohara, Jong‐Chol Cyong et al. · Planta Medica · 1984 · 58 citations